Radiopharm Theranostics (ASX:RAD) OCF Margin %: -641.57% (As of Jun. 2025)


What is Radiopharm Theranostics OCF Margin %?

Radiopharm Theranostics ASX:RAD -5.00% OCF Margin % is -641.57% as of Jun. 2025. The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Radiopharm Theranostics ranks worse than 80.4% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Radiopharm Theranostics's Cash Flow from Operations for the six months ended in Jun. 2025 was A$-14.43 Mil. Radiopharm Theranostics's Revenue for the six months ended in Jun. 2025 was A$2.25 Mil. Therefore, Radiopharm Theranostics's OCF Margin % for the quarter that ended in Jun. 2025 was -641.57%.

As of today, Radiopharm Theranostics's current OCF Yield % is -77.48%.

The historical rank and industry rank for Radiopharm Theranostics's OCF Margin % or its related term are showing as below:

ASX:RAD' s OCF Margin % Range Over the Past 10 Years
Min: -110177.78   Med: -7815.09   Max: -1008.67
Current: -1008.67

During the past 4 years, the highest OCF Margin % of Radiopharm Theranostics was -1008.67%. The lowest was -110177.78%. And the median was -7815.09%.

ASX:RAD's OCF Margin % is ranked worse than
80.4% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs ASX:RAD: -1008.67

Radiopharm Theranostics OCF Margin % Related Terms

Radiopharm Theranostics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Radiopharm Theranostics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Radiopharm Theranostics OCF Margin % Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
OCF Margin %
-110,177.78 -7,945.89 -7,684.28 -1,008.67

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 -1,605.20 -641.57

ASX:RAD vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Radiopharm Theranostics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's OCF Margin % falls into.


Radiopharm Theranostics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Radiopharm Theranostics's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-36.645/3.633
=-1,008.67 %

Radiopharm Theranostics's OCF Margin for the quarter that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-14.429/2.249
=-641.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -641.57% mean?
Radiopharm Theranostics (ASX:RAD) has a OCF Margin % of -641.57% as of Jun. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Radiopharm Theranostics and its competitors. According to the industry distribution chart, Radiopharm Theranostics ranks #771 out of 959 companies in the Biotechnology industry, placing it in the top 80.4%.
Is Radiopharm Theranostics' OCF Margin % too high?
Radiopharm Theranostics' current OCF Margin % is -641.57%. Based on the distribution chart, Radiopharm Theranostics ranks #771 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Radiopharm Theranostics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Radiopharm Theranostics ranks #771 out of 959 companies for OCF Margin %. This places Radiopharm Theranostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Radiopharm Theranostics and its competitors. Radiopharm Theranostics's current OCF Margin % is -641.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radiopharm Theranostics stock overvalued right now?
Radiopharm Theranostics (ASX:RAD) has a current OCF Margin % of -641.57%. The current OCF Margin % is -641.57%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Radiopharm Theranostics (ASX:RAD), the current OCF Margin % is -641.57% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Radiopharm Theranostics Business Description

Other Exchanges RADX:USA
Address 62 Lygon Street, Suite 1, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.